Lexeo Therapeutics Inc (NASDAQ: LXEO) on Tuesday, soared 28.90% from the previous trading day, before settling in for the closing price of $6.47. Within the past 52 weeks, LXEO’s price has moved between $1.45 and $11.72.
During the last 5-year period, the sales drop of Healthcare Sector giant was -99.98%. The company achieved an average annual earnings per share of 18.61%. With a float of $42.60 million, this company’s outstanding shares have now reached $54.00 million.
Lexeo Therapeutics Inc (LXEO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Lexeo Therapeutics Inc is 21.12%, while institutional ownership is 69.28%. The most recent insider transaction that took place on Aug 18 ’25, was worth 13,294. In this transaction Chief Technical Officer of this company sold 2,848 shares at a rate of $4.67, taking the stock ownership to the 60,372 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Chief Legal Officer sold 542 for $4.67, making the entire transaction worth $2,530. This insider now owns 62,556 shares in total.
Lexeo Therapeutics Inc (LXEO) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.89 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.67) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.24% during the next five years compared to -99.98% drop over the previous five years of trading.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Trading Performance Indicators
Lexeo Therapeutics Inc (LXEO) is currently performing well based on its current performance indicators. A quick ratio of 4.43 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.00 in one year’s time.
Technical Analysis of Lexeo Therapeutics Inc (LXEO)
Looking closely at Lexeo Therapeutics Inc (NASDAQ: LXEO), its last 5-days average volume was 2.21 million, which is a jump from its year-to-date volume of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 66.93%.
During the past 100 days, Lexeo Therapeutics Inc’s (LXEO) raw stochastic average was set at 91.63%, which indicates a significant increase from 86.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.56 in the past 14 days, which was higher than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.27, while its 200-day Moving Average is $4.36. However, in the short run, Lexeo Therapeutics Inc’s stock first resistance to watch stands at $8.85. Second resistance stands at $9.37. The third major resistance level sits at $9.85. If the price goes on to break the first support level at $7.85, it is likely to go to the next support level at $7.37. Now, if the price goes above the second support level, the third support stands at $6.85.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Key Stats
Market capitalization of the company is 450.37 million based on 54,001K outstanding shares. Right now, sales total 0 K and income totals -98,330 K. The company made 0 K in profit during its latest quarter, and -26,100 K in sales during its previous quarter.
